Levocet Syrup contains Levocetirizine dihydrochloride 2.5mg per 5ml, a third-generation non-sedative antihistamine used primarily for the symptomatic relief of allergic conditions. Levocetirizine is a selective antagonist of peripheral H1 receptors, effectively inhibiting the action of histamine, a key mediator in allergic responses. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria characterized by itching and hives. Levocet Syrup offers a convenient oral formulation suitable for pediatric patients who require precise dosing and ease of administration. The syrup’s pharmacokinetic profile ensures rapid absorption and a prolonged duration of action, providing sustained symptom control with once or twice daily dosing. Common adverse effects are generally mild and may include drowsiness, dry mouth, and fatigue, with a low incidence of sedation compared to first-generation antihistamines. Levocet Syrup should be used with caution in patients with renal impairment, and dosage adjustments may be necessary. It is contraindicated in individuals with known hypersensitivity to levocetirizine or any of the excipients. As with all medications, Levocet Syrup should be used under medical supervision to ensure optimal therapeutic outcomes and minimize potential risks.